Christopher Healy
Cardiovascular Disease · Indianapolis, INNPI 1033352877
Payments from drug & device makers
Across 616 payments — averaging $338.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$146K
- Boston Scientific$37K
- Medtronic$11K
- Abbott$6K
- Biotronik Inc.$6K
- Novartis$280
- plus $3K from 30 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 117 | $146,298 |
| Boston Scientific | 163 | $36,588 |
| Medtronic(2 entities) | 83 | $11,045 |
| Abbott | 82 | $6,189 |
| Biotronik Inc. | 29 | $5,657 |
| Novartis | 14 | $280 |
| Pfizer | 15 | $247 |
| Inari Medical, Inc. | 2 | $231 |
| AstraZeneca | 11 | $211 |
| Novo Nordisk | 9 | $198 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 12 | $169 |
| Bayer | 10 | $165 |
| Amgen | 9 | $146 |
| Cardiofocus, Inc. | 3 | $145 |
| Johnson & Johnson | 8 | $135 |
| Kestra Medical Technology Services, Inc. | 6 | $122 |
| Penumbra, Inc. | 4 | $110 |
| Terumo Medical Corporation | 4 | $89 |
| Boehringer Ingelheim | 5 | $86 |
| E.r. Squibb & Sons, L.L.C. | 5 | $73 |
| Kiniksa Pharmaceuticals International, PLC | 4 | $69 |
| Stryker | 1 | $61 |
| Altathera Pharmaceuticals LLC | 2 | $37 |
| Scpharmaceuticals Inc. | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 2 | $31 |
| Daiichi Sankyo Inc. | 2 | $31 |
| Merck | 2 | $29 |
| Amarin Pharma, Inc. | 2 | $29 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $26 |
| Atricure, Inc. | 1 | $23 |
| Angiodynamics, Inc. | 1 | $23 |
| Lantheus Medical Imaging, Inc. | 1 | $20 |
| Elutia, Inc. | 1 | $14 |
| Lundbeck LLC | 1 | $14 |
| Lexicon Pharmaceuticals, Inc. | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $11 |
How this compares
$208,646 in reported general payments places this provider in the 90th percentile of 408 cardiovascular disease providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Indianapolis
- Atul ChughIndianapolis$775K
- Noel DasguptaIndianapolis$744K
- Vijay RaoIndianapolis$706K
- Roopa RaoIndianapolis$481K
- Julie ClaryIndianapolis$475K
- James TrippiIndianapolis$449K
- John MillerIndianapolis$354K
- Richard KovacsIndianapolis$338K
- David KovacichIndianapolis$327K
- Jose Emanuel FinetIndianapolis$299K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.